Matches in SemOpenAlex for { <https://semopenalex.org/work/W3120060220> ?p ?o ?g. }
- W3120060220 endingPage "630" @default.
- W3120060220 startingPage "617" @default.
- W3120060220 abstract "The aim of this study was to surface-functionalize PEGylated liposomal doxorubicin (PLD) using anti-p32 CGKRK peptide to evaluate its anti-angiogenic and anti-tumour activities. CGKRK was conjugated to DSPE-mPEG2000-maleimide and post-inserted into PLD at 25, 50, 100, 200 and 400 peptides per each liposome and characterised for their size, zeta potential, drug loading, release properties; and cell binding, cell uptake and cytotoxicity on three C26, 4T1 and human umbilical vein endothelial cell (HUVEC) cell lines. The in vitro results indicated the better efficiency of the PLD-100 (PLD with 100 CGKRK) formulation on 4T1 and HUVEC cell lines. The results of anti-tube formation and spheroid assay indicated the efficiencies of the PLD-100 formulation compared with Caelyx®in vitro. The in vivo studies indicated the higher tumour accumulation of PLD-100 formulation in comparison with Caelyx® which also implied the higher survival rates in mice treated with PLD-100 formulation. Histological evaluations demonstrated that PLD-100 had no side-effects on major organs. In conclusion, the results of this study indicated that PLD-CGKRK- could efficiently target endothelial and tumour parenchymal cells which enhance the therapeutic efficacy of PLD and merits further investigation." @default.
- W3120060220 created "2021-01-18" @default.
- W3120060220 creator A5029572002 @default.
- W3120060220 creator A5031324372 @default.
- W3120060220 creator A5048139853 @default.
- W3120060220 creator A5060364685 @default.
- W3120060220 creator A5065998504 @default.
- W3120060220 creator A5069083861 @default.
- W3120060220 date "2021-03-08" @default.
- W3120060220 modified "2023-10-03" @default.
- W3120060220 title "Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide" @default.
- W3120060220 cites W1513897103 @default.
- W3120060220 cites W1567493631 @default.
- W3120060220 cites W1861735138 @default.
- W3120060220 cites W1963618034 @default.
- W3120060220 cites W1966125619 @default.
- W3120060220 cites W1977178747 @default.
- W3120060220 cites W1982629607 @default.
- W3120060220 cites W2000567082 @default.
- W3120060220 cites W2004109893 @default.
- W3120060220 cites W2008542507 @default.
- W3120060220 cites W2013425300 @default.
- W3120060220 cites W2029772834 @default.
- W3120060220 cites W2042539426 @default.
- W3120060220 cites W2045416947 @default.
- W3120060220 cites W2049760326 @default.
- W3120060220 cites W2078694420 @default.
- W3120060220 cites W2079260788 @default.
- W3120060220 cites W2096552337 @default.
- W3120060220 cites W2098533150 @default.
- W3120060220 cites W2106810178 @default.
- W3120060220 cites W2109048721 @default.
- W3120060220 cites W2117692326 @default.
- W3120060220 cites W2117976997 @default.
- W3120060220 cites W2126415088 @default.
- W3120060220 cites W2138346848 @default.
- W3120060220 cites W2143463421 @default.
- W3120060220 cites W2168202400 @default.
- W3120060220 cites W2174774056 @default.
- W3120060220 cites W2218983525 @default.
- W3120060220 cites W2462239453 @default.
- W3120060220 cites W2468843805 @default.
- W3120060220 cites W2538177344 @default.
- W3120060220 cites W2593833494 @default.
- W3120060220 cites W2596329858 @default.
- W3120060220 cites W2621175176 @default.
- W3120060220 cites W2621648704 @default.
- W3120060220 cites W2626864974 @default.
- W3120060220 cites W2749484673 @default.
- W3120060220 cites W2770640050 @default.
- W3120060220 cites W2783938965 @default.
- W3120060220 cites W2796781998 @default.
- W3120060220 cites W2800676430 @default.
- W3120060220 cites W2801418288 @default.
- W3120060220 cites W2807896387 @default.
- W3120060220 cites W2885843108 @default.
- W3120060220 cites W2890167612 @default.
- W3120060220 cites W2891009951 @default.
- W3120060220 cites W2901308741 @default.
- W3120060220 cites W2902924619 @default.
- W3120060220 cites W2923614237 @default.
- W3120060220 cites W2937066926 @default.
- W3120060220 cites W2937318865 @default.
- W3120060220 cites W2943978085 @default.
- W3120060220 cites W2962600786 @default.
- W3120060220 cites W2985152805 @default.
- W3120060220 cites W2990873661 @default.
- W3120060220 cites W3023994093 @default.
- W3120060220 cites W4232191614 @default.
- W3120060220 cites W4247347009 @default.
- W3120060220 cites W4256538966 @default.
- W3120060220 doi "https://doi.org/10.1080/1061186x.2020.1870230" @default.
- W3120060220 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33393376" @default.
- W3120060220 hasPublicationYear "2021" @default.
- W3120060220 type Work @default.
- W3120060220 sameAs 3120060220 @default.
- W3120060220 citedByCount "22" @default.
- W3120060220 countsByYear W31200602202021 @default.
- W3120060220 countsByYear W31200602202022 @default.
- W3120060220 countsByYear W31200602202023 @default.
- W3120060220 crossrefType "journal-article" @default.
- W3120060220 hasAuthorship W3120060220A5029572002 @default.
- W3120060220 hasAuthorship W3120060220A5031324372 @default.
- W3120060220 hasAuthorship W3120060220A5048139853 @default.
- W3120060220 hasAuthorship W3120060220A5060364685 @default.
- W3120060220 hasAuthorship W3120060220A5065998504 @default.
- W3120060220 hasAuthorship W3120060220A5069083861 @default.
- W3120060220 hasConcept C109316439 @default.
- W3120060220 hasConcept C12554922 @default.
- W3120060220 hasConcept C126322002 @default.
- W3120060220 hasConcept C1491633281 @default.
- W3120060220 hasConcept C150903083 @default.
- W3120060220 hasConcept C185154212 @default.
- W3120060220 hasConcept C185592680 @default.
- W3120060220 hasConcept C202751555 @default.
- W3120060220 hasConcept C207001950 @default.
- W3120060220 hasConcept C2776694085 @default.
- W3120060220 hasConcept C2781303535 @default.